These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
228 related items for PubMed ID: 8037259
1. Alprazolam blockade of CO2-provoked panic in patients with panic disorder. Sanderson WC, Wetzler S, Asnis GM. Am J Psychiatry; 1994 Aug; 151(8):1220-2. PubMed ID: 8037259 [Abstract] [Full Text] [Related]
2. Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients. Pols H, Verburg K, Hauzer R, Meijer J, Griez E. Biol Psychiatry; 1996 Nov 01; 40(9):913-7. PubMed ID: 8896779 [Abstract] [Full Text] [Related]
3. Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder. Schweizer E, Patterson W, Rickels K, Rosenthal M. Am J Psychiatry; 1993 Aug 01; 150(8):1210-5. PubMed ID: 8328566 [Abstract] [Full Text] [Related]
4. Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine. Schweizer E, Rickels K, Weiss S, Zavodnick S. Arch Gen Psychiatry; 1993 Jan 01; 50(1):51-60. PubMed ID: 8422222 [Abstract] [Full Text] [Related]
9. Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia. Lesser IM, Lydiard RB, Antal E, Rubin RT, Ballenger JC, DuPont R. Am J Psychiatry; 1992 Nov 01; 149(11):1556-62. PubMed ID: 1415824 [Abstract] [Full Text] [Related]
11. Carbon dioxide/oxygen challenge test in panic disorder. Perna G, Battaglia M, Garberi A, Arancio C, Bertani A, Bellodi L. Psychiatry Res; 1994 May 01; 52(2):159-71. PubMed ID: 7972572 [Abstract] [Full Text] [Related]
13. A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder. Lydiard RB, Lesser IM, Ballenger JC, Rubin RT, Laraia M, DuPont R. J Clin Psychopharmacol; 1992 Apr 01; 12(2):96-103. PubMed ID: 1573046 [Abstract] [Full Text] [Related]
14. Anxiogenic effects of CO2 and hyperventilation in patients with panic disorder. Gorman JM, Papp LA, Coplan JD, Martinez JM, Lennon S, Goetz RR, Ross D, Klein DF. Am J Psychiatry; 1994 Apr 01; 151(4):547-53. PubMed ID: 8147452 [Abstract] [Full Text] [Related]
15. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo. Keller MB, Lavori PW, Goldenberg IM, Baker LA, Pollack MH, Sachs GS, Rosenbaum JF, Deltito JA, Leon A, Shear K. J Affect Disord; 1993 May 01; 28(1):27-38. PubMed ID: 8326078 [Abstract] [Full Text] [Related]
16. A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO(2) models of experimental human anxiety. Bailey JE, Papadopoulos A, Seddon K, Nutt DJ. J Psychopharmacol; 2009 Mar 01; 23(2):117-22. PubMed ID: 18562427 [Abstract] [Full Text] [Related]